LabCompass

Jacob Al-Saleem

Immunology and Microbiology · The Ohio State University

OpenAlex ORCID
Mid career · publishing since 2013
T-cell and Retrovirus StudiesVector-Borne Animal DiseasesAnimal Disease Management and EpidemiologyCancer-related gene regulationComputational Drug Discovery Methods

Publications

16

Citations

354

Est. group size

—

Recurring co-author estimate

Active years

13

Publishing since 2013

Research summary
AI-generated

Jacob Al-Saleem's research focuses on retroviruses, particularly human T-cell leukemia virus (HTLV-1 and HTLV-2), studying viral proteins like Tax-1 and HBZ and their role in disease. He has also worked on computational approaches to drug discovery, including using knowledge graphs to identify potential COVID-19 treatments. This work bridges basic virology with computational methods for finding new therapeutic uses for existing drugs.

Retrovirus biology (HTLV-1/HTLV-2)Viral protein interactions and pathogenesisComputational drug repurposingT-cell immunologyVector-borne and animal disease epidemiology

Publication output has been low and irregular over the last decade, with several years of no recorded output and an average of less than one publication per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 0.4/year recently
2017: 1 publication172018: 1 publication182019: 3 publications319202021: 1 publication2122232024: 1 publication242025: 1 publication2526
Recent publications
Publishes in
  • Retrovirology×2
  • Journal of Chemical Information and Modeling×1
  • PLoS ONE×1
  • Frontiers in Microbiology×1
  • PLoS Pathogens×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile